This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
tag people 
World of DTC Marketing
JUNE 1, 2021
Kesselheim, a professor of medicine at Harvard Medical School via the Washington Post , says “the worst thing for people with Alzheimer’s would be to put out a product that doesn’t work.” Still, Alzheimer’s is a nasty disease, and people are desperate for treatment even if it only provided a slim chance of partial recovery.
187 
Medical Xpress
MARCH 8, 2023
Failure to enroll enough participants in trials can delay the arrival of new therapies in the clinic and inflate their eventual price tags. For example, a drug that proves effective for White patients might not work as well in people of other races or ethnicities.
105 This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Medical Xpress
NOVEMBER 23, 2022
People with one form of the genetic blood disorder hemophilia now have a one-time treatment with a $3.5 million price tag.
74 
Scienmag
JULY 4, 2022
Government policies often are presented with hefty price tags, but people often zone out as more zeros are added to the total cost.
80 
Medical Xpress
JANUARY 18, 2023
Most people remember emotional events—like their wedding day—very clearly, but researchers are not sure how the human brain prioritizes emotional events in memory.
76 
Rethinking Clinical Trials
APRIL 18, 2023
We have people with experience with post-viral symptoms, treating ME/CFS, general COVID knowledge, biomarker experience, clinical trials, patient-reported outcomes, and more. – As people think about the health measures and outcomes, can you describe the process for how to understand and select those types of measures? .
219 
Rethinking Clinical Trials
AUGUST 10, 2023
It’s important that people apply good judgement when utilizing these new technologies, especially in fields of science and medicine. Serious games pique the interest of people and can increase their likelihood of continuing a behavior. In an interactive video game, people interact with NPCs (non-player characters).
130 
Rethinking Clinical Trials
FEBRUARY 7, 2024
From January to September 2023, the Foundation conducted in-depth research and held 5 listening sessions to learn how people consume and understand health information. The spread of misinformation has accelerated, in part because more people than ever are accessing health information on the internet and via social media.
152 
pharmaphorum
DECEMBER 24, 2021
The anti-amyloid drug, which also claimed a breakthrough tag from the FDA in July, is being developed for the treatment of early-stage Alzheimer’s disease. The $56,000-a-year price tag for the drug, which has now been cut in half in the US, also hasn’t helped the drugmakers make a case for Aduhelm with US payers.
111 
World of DTC Marketing
SEPTEMBER 9, 2021
Chan School of Public Health, says, “at the moment, people are skeptical enough of the pharmaceutical industry that they’re going to have a tough time saying that if the government gets you a discount, you won’t get discoveries.”. Then there is the cost of people who refuse to get vaccinated against COVID.
222 
Rethinking Clinical Trials
OCTOBER 26, 2023
There is now a cure for Hepatitis C, but many people are not able to access it. Many people do not know they have Hepatitis C (about 40% of patients). Unless we take action, our system will be spending tens of billions of dollars for Hepatitis C care over the coming decades for people already infected.
Rethinking Clinical Trials
FEBRUARY 14, 2024
When people who are external to the VA view it as one homogeneous system, that is not the case. When people understood what we were trying to do, embed research into clinical care, people really engaged and a few regional directors made participation one of the drivers of research in their region and helped us get initial groundwork.
152 
Rethinking Clinical Trials
JULY 27, 2022
Given the history with other repurposed drugs, I was concerned people would not want to take Ivermectin. This was one of the reasons we gave people options about which drugs they were willing to take. What were some early lessons learned in terms of how to reach people given the hybrid nature of the study?
169 
Rethinking Clinical Trials
JANUARY 19, 2023
But this might obscure heterogeneity within groups, intersecting sources of vulnerability, and other vulnerable participants, such as people with dementia. Researchers seeking to enroll people living with dementia need a plan for assessing participants’ capacity to consent to research participation. That’s difficult.
130 
Rethinking Clinical Trials
MARCH 6, 2024
We see people visiting the fresh food pharmacies for up to 12 months. Were people eating less healthy meals for the non-program meals? When they get home do they give the food away, eat it themselves, throw it away, we don’t know. In terms of the types of food they had, they were not especially culturally diverse.
141 
World of DTC Marketing
SEPTEMBER 24, 2021
After an unstable period, they lost their CEO and some very good people who decided to abandon ship. Then, against the advisory panel’s advice, Aduhelm was approved, but insiders within the industry criticized both the FDA and Biogen weren’t sold on the drug or its price tag.
222 
pharmaphorum
APRIL 26, 2021
Using technologies such as VR and AI, the company aims to accelerate human growth and social rehabilitation in medical education and provide support for people with disabilities, as well as provide treatments for mental illness. It comprises more than 170 companies and employs 20,000 people across 20 countries worldwide.
122 
Rethinking Clinical Trials
SEPTEMBER 21, 2023
Nutrition incentive programs match SNAP dollars for people to use on fresh produce at supermarkets, which increases sales and consumption of produce in brick-and-mortar settings. Over 90% of people in the default and combination groups purchased at least one of the default fruits and/or vegetables in their cart.
130 
Rethinking Clinical Trials
SEPTEMBER 28, 2023
In areas of quality improvement people often do not consider cluster randomized design or people may be disappointed if they are randomized to usual care. For example, one local clinic did not have the room space, so the coaches called the family the day before then they could pop in quickly for a brief discussion.
269 
Rethinking Clinical Trials
OCTOBER 18, 2023
The World Health Organization defines social determinants of health as non-medical factors that influence health outcomes and conditions in which people are born, grow, work, live, and age, and the wider set of forces and systems shaping the conditions of daily life.
117 
pharmaphorum
DECEMBER 17, 2020
“When we talk about vaccines as health professionals, people who are vehemently anti-vaccine can take it out of context for their agenda. If you say vaccines don’t cause any harm and are the best things in the world, it can alienate people who are vaccine hesitant. That makes me hold back sometimes,” said Chiang.
97 
The Pharma Data
NOVEMBER 29, 2021
1.1.529 a variant of concern, named Omicron, on the advice of WHO’s Technical Advisory Group on Virus Evolution (TAG-VE). The number of people testing positive has risen in areas of South Africa affected by this variant, but epidemiologic studies are underway to understand if it is because of Omicron or other factors.
52 
pharmaphorum
OCTOBER 3, 2022
ALS affects over 30,000 people in the US. Following news of Relyvrio’s $158,000 annual price tag, both ALS advocates and outside observers have voiced outrage at the cost. The post Amylyx ALS drug draws criticism over $158,000 price tag appeared first on. It can lead to progressive paralysis and death.
52 
Rethinking Clinical Trials
DECEMBER 20, 2023
Discussion Themes -What have been the challenges in developing and identifying people interested in working in clinical trials? Tags #pctGR, @Collaboratory1 The post Grand Rounds December 15, 2023: Diversifying Clinical Trials: A Path Forward (Roxana Mehran, MD, FACC, FAHA, MSCAI, FESC) appeared first on Rethinking Clinical Trials.
169 Rethinking Clinical Trials
JANUARY 9, 2024
Unfortunately, this can rarely happen, so people consider using the missing at random (MAR) model, which models the missingness process using the observed data in cluster randomized trials. Most of an analysis can proceed using complete data, so this isn’t an issue.
275 
Rethinking Clinical Trials
FEBRUARY 28, 2024
There is agreement that trials need to meet the people, at home and covering clinical trial deserts. From my perspective, if one key goal for NIH is to reach people in underserved communities having sound practices for decentralized methods will be important. Lindsell, PhD) appeared first on Rethinking Clinical Trials.
141 
World of DTC Marketing
JUNE 23, 2021
When I didn’t understand something, I went to the medical people on the team to gain insights. Not to mention the $56,000 annual price tag. A common counter-argument to the amyloid hypothesis is that plaques are found in the brains of many elderly people with normal cognition.
218 
pharmaphorum
NOVEMBER 19, 2021
The cost-effectiveness agency had turned down Evrysdi (risdiplam) in draft guidance published in June, saying it was too expensive, but after negotiations with Roche has reached a deal that will make the drug available to around 1,500 people in England. million price tag make it is the most expensive treatment ever approved for NHS funding.
98 
Rethinking Clinical Trials
DECEMBER 6, 2023
Discussion Themes -Most people have analyzed stepped-wedge designs with the immediate treatment model. Tags #pctGR, @Collaboratory1 The post Grand Rounds December 1, 2023: Guidelines for Design and Analysis of Stepped-Wedge Trials (James P. Should they go back and analysis with a more flexible model?
152 
Rethinking Clinical Trials
AUGUST 23, 2022
Is there low hanging fruit we should encourage people to focus on? The face-to-face component, the time in front of individuals is a critical step to being welcomed and to engaging people in rural settings. Discussion Themes. -Is Where to start? This is an issue that a number of institutions have been thinking about for some time.
130 
pharmaphorum
AUGUST 17, 2020
In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Before, there would have been 12 people in a meeting room with a notepad. “We’re About the authors.
97 Rethinking Clinical Trials
AUGUST 30, 2023
We tried collecting some of the information at the end of the visit and found people were in a hurry. We had to balance the proportion of people who were going to respond to the survey against the timing of when the survey was delivered. I am still optimistic that we will see some improvements in the outcomes we specified.
141 Rethinking Clinical Trials
AUGUST 22, 2022
Patients with diabetes or prediabetes were not excluded (except for those on insulin or sulfonylurea); pregnant patients were not excluded for the Metformin arm; the trial restricted participants to people who were overweight or obese to enrich the population for having a high risk of outcomes and for anti-inflammatory hypotheses around Metformin.
130 Rethinking Clinical Trials
JANUARY 17, 2024
The criteria were updated in June 2020 when it was determined that Remdesivir was safe for pregnant people, increasing odds because 2 lives could be saved. Tags #pctGR, @Collaboratory1 The post Grand Rounds January 12, 2024: Design and Implementation of a Weighted Lottery to Equitably Allocate Scarce Covid-19 Resources (Erin K.
169 
Rethinking Clinical Trials
OCTOBER 11, 2023
Moyer, PhD Statistician, NIH Office of Disease Prevention Slides Keywords Implementation; Study design; Hybrid; Clustered; DECIPHeR Key Points People often contest that hybrid designs are not as rigorous as they should be. so that people will use the research we’ve done. How can this kind of collaboration happen more widely?
152 
pharmaphorum
NOVEMBER 16, 2021
Epilepsy affects more than 600,000 people in the UK and for some, seizures can be life-threatening. It is estimated that around 1,000 people die in the UK every year because of the condition. “We look forward to the full technology appraisal guidance (TAG) which is due to be published in early December 2021,” he added. .
98 
pharmaphorum
NOVEMBER 24, 2021
Digital health company Pear Therapeutics has won FDA breakthrough device status for reSET-A, its development-stage prescription digital therapeutic (DTx) for people with alcohol-use disorder. The post Pear claims breakthrough tag for alcohol use disorder DTx appeared first on. Photo by thom masat on Unsplash.
59 
Rethinking Clinical Trials
MAY 25, 2023
While people may be interested in specific subpopulations or outcomes, the confidence interval is not adjusted for multiple comparisons, so slicing the data could risk spurious findings. -The Discussion Themes -Researchers decided to use a two-arm study with only Aspirin because of its low cost and its use in orthopedic arthroplasty.
130 
Rethinking Clinical Trials
SEPTEMBER 30, 2022
The home visit services were covered through a Medicaid waiver that allowed the Nurse Family Partnership (NFP) to serve about 4,000 people over 4 years (up to 40 visits at home). We are largely looking at state data but are thinking about federal data that we can access. pctGR, @Collaboratory1.
130 
XTalks
APRIL 18, 2024
If approved, the test could help rapidly “broaden access to a more timely and accurate diagnosis and potentially mitigate the impact of Alzheimer’s disease on people and society,” said Roche in a statement announcing the breakthrough designation.
Pharmaceutical Technology
JULY 14, 2022
Despite this high number, orphan diseases are rare by definition, affecting around one in 2,000 people as defined by the European Union. Due to the high price tags associated with these speciality medicines, innovators have naturally favoured big markets with high GDP such as the US and EU-5 (Germany, France, Spain, Italy, and the UK). “The
147 
pharmaphorum
JANUARY 5, 2022
Teliso-V (telisotuzumab vedotin) is pitching to become the first targeted cancer treatment for people with non-small cell lung cancer (NSCLC) whose tumours overexpress c-Met. The post FDA gives AbbVie’s c-Met lung cancer ADC a breakthrough tag appeared first on.
111 
Drug Discovery World
DECEMBER 20, 2022
Concerns about the high price tag have been raised in an article in Nature, particularly whether it will be affordable for low to middle-income countries. . Thank you to all for the role you have played in helping us reach this regulatory milestone in Europe.” . World’s most expensive drug.
52 
Rethinking Clinical Trials
AUGUST 3, 2023
All of the necessary context should be included in the figure itself so people cannot accidentally snip it away from the relevant context. Tags #pctGR, @Collaboratory1 The post Grand Rounds July 28, 2023: How Can Researchers Fight Misinformation About Medicine? Bergstrom, PhD) appeared first on Rethinking Clinical Trials.
130
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content